FavId patient-specific NHL idiotype protein conjugated to KLH immunostimulatory protein regulatory update

By WIR Staff | May 24, 2004 | 7:00 AM GMT

Favrille received an SPA from FDA for a Phase III

Read the full 102 word article

How to gain access

Continue reading with a
two-week free trial.